No label defined (Q3303676)

From EU Knowledge Graph
Revision as of 13:03, 24 October 2021 by DG Regio (talk | contribs) (‎Changed label, description and/or aliases in en: Setting new description)
Jump to navigation Jump to search
Project Q3303676 in Germany
Language Label Description Also known as
English
No label defined
Project Q3303676 in Germany

    Statements

    country
    Germany
    0 references
    budget
    234,573.04 Euro
    0 references
    start time
    1 October 2017
    0 references
    end time
    30 September 2019
    0 references
    beneficiary name (string)
    Universitätsklinikum Hamburg-Eppendorf (Öffentlich-rechtliche Körperschaft)
    0 references
    programme
    Hamburg - ERDF
    0 references
    postal code
    20251
    0 references
    summary
    Die Entwicklung von optimierten toleranz-induzierenden Nanopartikeln ("OpToPas") mit verbessertem Funktions- und Verträglichkeitsprofil um krankheitsauslösende Antigene über die Blutbahn zu den LSECs zu bringen (sog. "Drug Targeting"). (German)
    0 references

    Identifiers

    German Kohesio ID
    DE_TEMPORARY_6474
    0 references
     
    Retrieved from "https://linkedopendata.eu/w/index.php?title=Item:Q3303676&oldid=13347258"